Summit Therapeutics (SMMT)
(Delayed Data from NSDQ)
$10.49 USD
+0.51 (5.11%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $10.31 -0.18 (-1.72%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.06 | 0.00% |
Earnings Summary
For their last quarter, Summit Therapeutics (SMMT) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 16.67%. Look out for SMMT's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.06 per share, reflecting a year-over-year decrease of 200%.
Earnings History
Price & Consensus
Zacks News for SMMT
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?
SMMT: What are Zacks experts saying now?
Zacks Private Portfolio Services